BR0010652A - Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados - Google Patents

Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados

Info

Publication number
BR0010652A
BR0010652A BR0010652-6A BR0010652A BR0010652A BR 0010652 A BR0010652 A BR 0010652A BR 0010652 A BR0010652 A BR 0010652A BR 0010652 A BR0010652 A BR 0010652A
Authority
BR
Brazil
Prior art keywords
oxo
beta
derivatives
amino
pyridinepropanoic
Prior art date
Application number
BR0010652-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Judith H Cohen
Michael Justus
Cynthia A Maryanoff
Armin Rossler
Fridtjof Harmen Schroder
Kirk L Sorgi
Frank John Villani Jr
Christian Weh
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of BR0010652A publication Critical patent/BR0010652A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR0010652-6A 1999-03-22 2000-03-21 Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados BR0010652A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12567199P 1999-03-22 1999-03-22
PCT/US2000/007462 WO2000056730A1 (en) 1999-03-22 2000-03-21 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES

Publications (1)

Publication Number Publication Date
BR0010652A true BR0010652A (pt) 2002-07-16

Family

ID=22420863

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010652-6A BR0010652A (pt) 1999-03-22 2000-03-21 Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados

Country Status (22)

Country Link
US (2) US6515130B1 (2)
EP (1) EP1165543B1 (2)
JP (1) JP2002540108A (2)
KR (1) KR20020019895A (2)
CN (1) CN1351600A (2)
AT (1) ATE242235T1 (2)
AU (1) AU775413B2 (2)
BR (1) BR0010652A (2)
CA (1) CA2368024A1 (2)
CZ (1) CZ20013431A3 (2)
DE (1) DE60003169T2 (2)
DK (1) DK1165543T3 (2)
ES (1) ES2199805T3 (2)
HK (1) HK1046272A1 (2)
HR (1) HRP20010767A2 (2)
HU (1) HUP0201262A3 (2)
MX (1) MXPA01009615A (2)
PT (1) PT1165543E (2)
SK (1) SK13562001A3 (2)
UA (1) UA67832C2 (2)
WO (1) WO2000056730A1 (2)
YU (1) YU74601A (2)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2225859C2 (ru) 1999-03-22 2004-03-20 Орто-Макнейл Фармасьютикал, Инк. Синтез 3-амино-3-арилпропаноатов
CA2457965C (en) * 2001-09-21 2010-06-01 Sanofi-Synthelabo Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
JP6243335B2 (ja) 2011-08-17 2017-12-06 ピラマル イメージング ソシエテ アノニム 血小板固有の糖タンパク質IIb/IIIaに結合する化合物と血栓造影のためのその使用
CA2900595A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
HRP20200437T1 (hr) 2013-02-20 2020-09-04 Reuter Chemische Apparatebau E.K. Proces za pripremu enantiomerom obogaćenog 3-aminopiperidina
US20160068486A1 (en) 2013-04-22 2016-03-10 Reuter Chemische Apparatebau Kg Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
KR102548998B1 (ko) 2020-03-31 2023-06-29 재단법인 아산사회복지재단 혈전영상을 위한 방사성의약품 및 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58243B1 (en) 1983-12-07 1993-08-11 Lonza Ag A process for the preparation of optically-active 3-amino carboxylic acids
US5254573A (en) 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
DE69429328T2 (de) * 1993-09-22 2002-06-13 Fujisawa Pharmaceutical Co., Ltd. N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds
EP0888302A1 (en) * 1996-03-13 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
ES2243996T3 (es) * 1996-05-01 2005-12-01 Ortho-Mcneil Pharmaceutical, Inc. Derivados carboxamida de pirrolidina, piperidina y hexahidroazepina utilizados en el tratamiento de trastornos de trombosis.
EP0912495B1 (en) 1996-07-12 2001-11-21 G.D. SEARLE & CO. Asymetric synthesis of chiral beta-amino acids
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders

Also Published As

Publication number Publication date
HK1046272A1 (zh) 2003-01-03
YU74601A (sh) 2004-05-12
DK1165543T3 (da) 2003-09-29
EP1165543B1 (en) 2003-06-04
HU0201262D0 (2) 2002-05-29
AU775413B2 (en) 2004-07-29
CZ20013431A3 (cs) 2003-04-16
DE60003169D1 (de) 2003-07-10
ATE242235T1 (de) 2003-06-15
JP2002540108A (ja) 2002-11-26
WO2000056730A1 (en) 2000-09-28
CA2368024A1 (en) 2000-09-28
HRP20010767A2 (en) 2002-12-31
MXPA01009615A (es) 2003-07-21
ES2199805T3 (es) 2004-03-01
SK13562001A3 (sk) 2002-08-06
HUP0201262A2 (en) 2002-08-28
US6515130B1 (en) 2003-02-04
DE60003169T2 (de) 2005-10-27
AU3766100A (en) 2000-10-09
US20020137937A1 (en) 2002-09-26
UA67832C2 (uk) 2004-07-15
HUP0201262A3 (en) 2003-12-29
EP1165543A1 (en) 2002-01-02
CN1351600A (zh) 2002-05-29
PT1165543E (pt) 2003-10-31
KR20020019895A (ko) 2002-03-13

Similar Documents

Publication Publication Date Title
TR200201072T2 (tr) 4-Triflorometilsulfinilpirazol türevi hazırlama süreci
BR0109109A (pt) Composto, uso do mesmo, processo para prepará-lo, composição farmacêutica, e, método de tratar um estado doentio mediado por ccr5 em mamìferos
BR0111230A (pt) Composto, e, uso e processo para a preparação do mesmo
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
DE60137273D1 (de) Verfahren zur Herstellung von 4-Phenoxy chinolin Derivaten
TR200400859T4 (tr) Yeni heterosiklik bileşikler, özellikle antibakteriyel preparatları.
BR0014225A (pt) Derivados de pirazol
BR0114252A (pt) Derivados de nitrosodifenilamina
ES2243579T3 (es) Derivados de pirazolopirideno.
BR0010652A (pt) Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados
BR9911250A (pt) Processo para preparação de compostos
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
HU9800865D0 (en) Condensed piperidine compounds
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR0112745A (pt) Processo para a preparação de arilacetilaminotiazóis
BR0007982A (pt) Processo para a preparação de um composto, e,composto
BR0210894A (pt) Derivados de benzo(g) quinolina
BR0002287A (pt) Compostos de piridina ou piperidina substituìdas, processo para preparação deles e composições farmacêuticas contendo-os
FR2806726B1 (fr) Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues
BR0113170A (pt) Processo para a preparação de dinapsolina
BR0308601A (pt) inibidores de carboxipeptidase b de plasma
HU0004701D0 (2)
BRPI9807312B8 (pt) derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE60030118D1 (de) Zwischenprodukte zur synthese von benzimidazolverbindungen und ein verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.